Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 1.053B
March 31, 2026 1.103B
December 31, 2025 1.202B
September 30, 2025 580.01M
June 30, 2025 629.14M
March 31, 2025 698.57M
December 31, 2024 839.98M
September 30, 2024 999.07M
June 30, 2024 1.035B
March 31, 2024 1.129B
December 31, 2023 1.169B
September 30, 2023 1.155B
June 30, 2023 1.225B
March 31, 2023 937.02M
December 31, 2022 1.011B
September 30, 2022 958.04M
June 30, 2022 853.69M
March 31, 2022 962.27M
Date Value
December 31, 2021 932.75M
September 30, 2021 1.486B
June 30, 2021 1.792B
March 31, 2021 1.940B
December 31, 2020 1.795B
September 30, 2020 1.013B
June 30, 2020 937.83M
March 31, 2020 520.09M
December 31, 2019 522.80M
September 30, 2019 522.96M
June 30, 2019 545.63M
March 31, 2019 466.86M
December 31, 2018 418.96M
September 30, 2018 271.34M
June 30, 2018 263.43M
March 31, 2018
December 31, 2017 221.32M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Natera, Inc. 1.092B
NeoGenomics, Inc. 145.54M
Quest Diagnostics, Inc. 626.00M
Labcorp Holdings, Inc. 141.80M
OPKO Health, Inc. 300.76M